Mario Paolo Colombo
Overview
Explore the profile of Mario Paolo Colombo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
1633
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Ferrara R, Milani M, Garassino M, Colombo M, Sangaletti S
J Thorac Oncol
. 2022 Feb;
17(3):e35-e38.
PMID: 35216738
No abstract available.
12.
Majorini M, Colombo M, Lecis D
Cancer Res
. 2022 Jan;
82(8):1439-1447.
PMID: 35045983
Tumor outcome is determined not only by cancer cell-intrinsic features but also by the interaction between cancer cells and their microenvironment. There is great interest in tumor-infiltrating immune cells, yet...
13.
Bellone M, Brevi A, Bronte V, Dusi S, Ferrucci P, Nistico P, et al.
Cancer Immunol Immunother
. 2022 Jan;
71(7):1787-1794.
PMID: 35034143
No abstract available.
14.
Bongiorno R, Colombo M, Lecis D
J Exp Clin Cancer Res
. 2021 Dec;
40(1):376.
PMID: 34852841
Nonsense-mediated mRNA decay (NMD) is a highly conserved cellular surveillance mechanism, commonly studied for its role in mRNA quality control because of its capacity of degrading mutated mRNAs that would...
15.
Vernieri C, Fuca G, Ligorio F, Huber V, Vingiani A, Iannelli F, et al.
Cancer Discov
. 2021 Nov;
12(1):90-107.
PMID: 34789537
In tumor-bearing mice, cyclic fasting or fasting-mimicking diets (FMD) enhance the activity of antineoplastic treatments by modulating systemic metabolism and boosting antitumor immunity. Here we conducted a clinical trial to...
16.
Pizzamiglio S, Ciniselli C, Triulzi T, Gargiuli C, De Cecco L, de Azambuja E, et al.
Clin Cancer Res
. 2021 Sep;
27(23):6307-6313.
PMID: 34548320
Purpose: Little is known about the efficacy of HER2-targeted therapy in patients with breast cancer showing different HER2-pathway dependence and immune phenotypes. Herein, we report a NeoALTTO exploratory analysis evaluating...
17.
Camelliti S, Le Noci V, Bianchi F, Storti C, Arnaboldi F, Cataldo A, et al.
Cancers (Basel)
. 2021 Aug;
13(16).
PMID: 34439233
Background: A combination of TLR9 agonists and an anti-PD-1 antibody has been reported to be effective in immunocompetent mice but the role of innate immunity has not yet been completely...
18.
Giussani M, Ciniselli C, De Cecco L, Lecchi M, Dugo M, Gargiuli C, et al.
Cancers (Basel)
. 2021 Aug;
13(16).
PMID: 34439180
In population-based screens, tissue biopsy remains the standard practice for women with imaging that suggests breast cancer. We examined circulating microRNAs as minimally invasive diagnostic biomarkers to discriminate malignant from...
19.
Sangaletti S, Ferrara R, Tripodo C, Garassino M, Colombo M
Cancer Immunol Immunother
. 2021 Apr;
70(9):2429-2438.
PMID: 33797567
Lung is a specialized tissue where metastases from primary lung tumors takeoff and those originating from extra-pulmonary sites land. One commonality characterizing these processes is the supportive role exerted by...
20.
Nato G, Corti A, Parmigiani E, Jachetti E, Lecis D, Colombo M, et al.
Sci Rep
. 2021 Jan;
11(1):651.
PMID: 33436685
We xeno-transplanted human neural precursor cells derived from induced pluripotent stem cells into the cerebellum and brainstem of mice and rats during prenatal development or the first postnatal week. The...